| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 04/11/2001 | EP1089998A2 Epothilone derivatives and their synthesis and use |
| 04/11/2001 | CN1291239A Fermentative preparation process for cytostatics and crystal form thereof |
| 04/11/2001 | CN1290745A Isolated biological synthesis of elliptone |
| 04/11/2001 | CN1290679A Method for preparing dibenzyl sorbitol |
| 04/10/2001 | US6214865 Anticancer agent |
| 04/05/2001 | WO2000061139A8 Anticonvulsant derivatives useful in reducing blood glucose levels |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1088098A2 Fitness assay and associated methods |
| 04/04/2001 | EP1087975A2 Epothilone minor constituents |
| 04/04/2001 | EP1087960A1 Macrocyclic analogs and methods of their use and preparation |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/03/2001 | US6211412 Reacting beta-keto ester with hydrogenating agent in presence of asymmetric organometallic molecular catalyst comprising metal atom having one or more chiral ligands coupled thereto, converting hydroxyester formed to epothilone precursor |
| 04/03/2001 | US6211369 Spiro compounds and the use thereof |
| 04/03/2001 | US6211363 Taxane compounds; antitumor agents |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211107 Process for expoxidizing prochiral olefins and a catalyst therefor and intermediates for making the catalyst |
| 04/03/2001 | US6210938 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 04/03/2001 | CA2066234C Activation compounds and methods for nucleic acid sterilization |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086952A1 Therapeutic agents |
| 03/28/2001 | EP1086107A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085886A1 Protecting neurons from ischemia |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP0910428A4 Photopheresis treatment of chronic hcv infections |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/27/2001 | US6207084 Naphthopyrans annelated in C6-C7, their preparation and compositions and (CO)polymer matrices containing them |
| 03/27/2001 | US6206988 Hexanitrohexaazaisowurtzitane compositions and explosive compositions containing the same |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/22/2001 | WO2001019812A1 Novel photochromic naphthopyrans |
| 03/21/2001 | EP1084269A1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 03/21/2001 | EP1084170A1 Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | CN1063445C Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
| 03/20/2001 | US6204388 Using blocking agent |
| 03/20/2001 | CA2019798C Fucosidase inhibitors |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/14/2001 | EP0773782B1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 03/14/2001 | CN1287121A Method of preparing ginkalide A and B as medicine from ginkgo leaf or its extract |
| 03/13/2001 | US6201134 Diaminorhodamine derivatives |
| 03/13/2001 | US6201004 Dioxino derivatives and their use as therapeutic agents |
| 03/13/2001 | US6200932 As pesticide and herbicide |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/08/2001 | WO2001016127A1 Chromone derivatives, process for the preparation of the same and uses thereof |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | DE10039377A1 Thermochromic liquid crystal medium, useful for the production of inks for the security marking of documents, comprises a liquid crystalline mixture and a chiral doping agent. |
| 03/07/2001 | EP1081151A1 Novel physiologically active substances |
| 03/07/2001 | EP1081150A1 4-Oxatricyclo(4.3.1.1-3,8)undecan-5-one derivatives and process for producing the same |
| 03/07/2001 | EP1080081A1 Benzofuroxan derivatives and their use in treating angina pectoris |
| 03/07/2001 | EP1079829A1 Use of benzofuroxan derivatives in treating angina pectoris |
| 03/07/2001 | CN1062866C Bryostatin as anticancer active compound |
| 03/06/2001 | US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 03/06/2001 | US6197767 Arglabin compounds and therapeutic uses thereof |
| 03/01/2001 | WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/01/2001 | WO2000066577A3 Brigded cycloalkanes as thromboxane ligands without blood clotting effects |
| 03/01/2001 | WO2000049019A3 Novel epothilone derivatives, method for producing them and their pharmaceutical use |
| 03/01/2001 | WO1999043314A9 Farnesyl-protein transferase inhibitors |
| 03/01/2001 | CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/28/2001 | EP1077980A2 Epothilone derivatives, a method for the production thereof, and their use |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | CN1285352A Preparation for lignal like material |
| 02/27/2001 | US6194586 Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols |
| 02/27/2001 | US6194405 3,3a,8,12b-tetrahydro-n-methyl-2h-dibenzo(3,4:6,7)-cyclohepta( 1,2-b)-furan-2-methanamine, for example; anxiolytic agents, antidepressants, sleep and sexual disorders, psychological, cardiovascular and gastrointestinal disorders |
| 02/27/2001 | US6194181 Producing epothiolones in a culture medium by providing microorganisms such as myxobacteria which produce epothiolones, and adding a complex-forming agent soluble in the culture medium, such as cyclodextrins; antitumor agents |
| 02/27/2001 | US6194139 Using a psoralen compound |
| 02/27/2001 | CA2012267C Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 02/22/2001 | WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use |
| 02/22/2001 | DE10025830A1 New 4-acyl-2,3-dihydro-benzofuran or -benzothiophene derivatives, useful as pre- or post-emergence, total or selective herbicides or as plant growth inhibitors |
| 02/21/2001 | EP1077227A1 Stabilizer mixtures |
| 02/21/2001 | CN1285003A Screening appays for the detection and diagnosis of influenza virus |
| 02/21/2001 | CN1285001A Methods for simultaneous identification of novel biological targets and lead structures for drug development |
| 02/21/2001 | CN1284897A Batch devices for reduction of compounds from biological compositions containing cells and methods of use |
| 02/21/2001 | CN1284896A Flow device for the reduction of compounds from biological compositions and methods of use |
| 02/20/2001 | US6191163 Anticonvulsant derivatives useful in lowering lipids |
| 02/15/2001 | WO2001010869A1 Bioactive compound |
| 02/14/2001 | EP1075476A1 Novel benzimidazoles and benzoxazoles |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP0865441B1 1,2,3-thiadiazole carboxylic acid (thio)esters and the use thereof as a pest control agent or as a microbicide |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 02/14/2001 | EP0773964B1 Gas phase production of polydienes |
| 02/13/2001 | US6187810 Administering to improve the therapeutic effect and the bioavailability of known medicaments; administering to diminish acute or chronic toxicity of a natural alkaloid, cardiac glycoside or synthetic drug |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009114A1 Hiv integrase inhibitors |
| 02/08/2001 | WO2001009094A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000056737A3 Calanolides for inhibiting btk |